Dr. Hanlin L. Wang, MD

Dr. Wang practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Wang's NPI, 1487671913, was assigned on July 17, 2006. Dr. Wang graduated from Hubei Medical University in 1982. Dr. Wang holds California license C52688.

Dr. Wang's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Wang's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Department of Pathology and Laboratory. Dmand AI also links Dr. Wang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Wang is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Wang's licenses on file in 3 states: California, Missouri and Illinois.

CMS data shows 4,312 Medicare services from Dr. Wang across 12 procedure codes in 2024, for 788 Medicare patients. Medicare paid $146,232 for them.

CMS counts 788 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 437 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 55, with 52% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 108 papers to Dr. Wang, published from 2006 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Immunohistochemistry, Biomarkers, Tumor and Adenocarcinoma. Dr. Wang has published most often in Am J Surg Pathol. Dr. Wang's most frequent co-authors are Deepti Dhall, Xuemo Fan, MD and Jinping Lai.

CMS Open Payments shows 8 general payments to Dr. Wang from 3 drug and device companies from 2022 to 2023. Consulting fees make up the largest share, 93% of the total. Bristol-Myers Squibb Company paid the most, $14,600.

Dr. Wang graduated from Hubei Medical University in 1982.

Dr. Wang is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross and Blue Shield of Kansas City. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.